We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.36B
AUM Growth
-$421M
Cap. Flow
-$494M
Cap. Flow %
-36.22%
Top 10 Hldgs %
24.41%
Holding
4,677
New
965
Increased
1,296
Reduced
1,507
Closed
833

Sector Composition

Rank Sector Weight
1 Industrials 7.55%
2 Technology 7.19%
3 Financials 6.96%
4 Healthcare 6.81%
5 Consumer Discretionary 5.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUR icon
2526
Pluri
PLUR
$19.6M
$15K ﹤0.01%
143
-24
-14% -$2.48K
SUPN icon
2527
Supernus Pharmaceuticals
SUPN
$2.77B
$15K ﹤0.01%
+289
New +$14.3K
TITN icon
2528
Titan Machinery
TITN
$445M
$15K ﹤0.01%
922
-1,608
-64% -$25.4K
TMF icon
2529
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
$2.18B
$15K ﹤0.01%
89
-98
-52% -$18.3K
AD
2530
Array Digital Infrastructure
AD
$3.05B
$15K ﹤0.01%
330
-85
-20% -$3.43K
VHC icon
2531
VirnetX Holding Corp
VHC
$63.1M
$15K ﹤0.01%
+163
New +$11.1K
VOC icon
2532
VOC Energy
VOC
$51.9M
$15K ﹤0.01%
2,711
+2,374
+704% +$13.5K
VRTS icon
2533
Virtus Investment Partners
VRTS
$1.1B
$15K ﹤0.01%
129
-1,086
-89% -$138K
XIFR
2534
XPLR Infrastructure LP
XIFR
$1.08B
$15K ﹤0.01%
+316
New +$15K
INFN
2535
DELISTED
Infinera Corporation Common Stock
INFN
$15K ﹤0.01%
+2,019
New +$17.2K
QUOT
2536
DELISTED
Quotient Technology Inc
QUOT
$15K ﹤0.01%
994
+594
+149% +$8.66K
TESS
2537
DELISTED
Tessco Technologies Inc
TESS
$15K ﹤0.01%
980
-4,869
-83% -$84.1K
LEJU
2538
DELISTED
Leju Holdings Limited American Depositary Shares, each representing ten (10) Ordinary Shares
LEJU
$15K ﹤0.01%
848
+646
+320% +$11.2K
CNBKA
2539
DELISTED
Century Bancorp Inc/Mass
CNBKA
$15K ﹤0.01%
213
-673
-76% -$50.4K
CHK
2540
DELISTED
Chesapeake Energy Corporation
CHK
$15K ﹤0.01%
17
-172
-91% -$157K
ARRY
2541
DELISTED
Array Biopharma Inc
ARRY
$15K ﹤0.01%
+1,007
New +$15.4K
LOXO
2542
DELISTED
Loxo Oncology, Inc
LOXO
$15K ﹤0.01%
+85
New +$14.3K
SCG
2543
DELISTED
Scana
SCG
$15K ﹤0.01%
+397
New +$15.2K
CMO
2544
DELISTED
Capstead Mortgage Corp.
CMO
$15K ﹤0.01%
1,887
+987
+110% +$8.31K
BLUE
2545
DELISTED
bluebird bio
BLUE
$14K ﹤0.01%
7
-92
-93% -$190K
BMA icon
2546
Banco Macro
BMA
$5.35B
$14K ﹤0.01%
330
-3,737
-92% -$201K
CBAN icon
2547
Colony Bankcorp
CBAN
$467M
$14K ﹤0.01%
802
+55
+7% +$971
CHGG icon
2548
Chegg
CHGG
$102M
$14K ﹤0.01%
490
-359
-42% -$10.7K
CRVS icon
2549
Corvus Pharmaceuticals
CRVS
$1.17B
$14K ﹤0.01%
1,670
+137
+9% +$1.37K
CTLP
2550
DELISTED
Cantaloupe
CTLP
$14K ﹤0.01%
1,951
+1,556
+394% +$21.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2018 Portfolio in Review

As of Q3 2018, Tower Research Capital (TRC) held 4,677 positions worth $1.36B, down 24% from $1.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) withdrew a net $494M in Q3 2018, closing 833 positions and reducing 1,507 holdings. Its most notable exit was NVIDIA, an estimated $6.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 7.5% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.3M.

  • Tower Research Capital (TRC)'s largest Q3 2018 buy was Vanguard S&P 500 ETF: 53,562 shares worth $14.3M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $151M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2018 reduction was Apple, cutting an estimated $48.1M.
  • Tower Research Capital (TRC) fully exited NVIDIA in Q3 2018, selling an estimated $6.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.36B portfolio in Q3 2018.
  • Tower Research Capital (TRC) opened 965 new positions and closed 833 in Q3 2018.
  • Tower Research Capital (TRC)'s portfolio value fell 24% quarter-over-quarter to $1.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2018, filed 13 Nov 2018.